Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,640.00
+100.00 (1.81%)
At close: Aug 21, 2025

Sinsin Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2020
86,47282,37694,66484,65197,850138,658
Upgrade
Market Cap Growth
7.32%-12.98%11.83%-13.49%-29.43%34.02%
Upgrade
Enterprise Value
132,744122,361135,899130,024145,574183,301
Upgrade
Last Close Price
5700.005430.006170.925463.416258.038867.97
Upgrade
PE Ratio
20.7716.8520.2319.18-382.34
Upgrade
PS Ratio
0.810.770.920.921.322.07
Upgrade
PB Ratio
1.271.261.531.421.792.47
Upgrade
P/TBV Ratio
1.281.261.531.431.802.49
Upgrade
P/FCF Ratio
36.4818.56-18.59--
Upgrade
P/OCF Ratio
19.0513.8624.0915.504220.6674.34
Upgrade
EV/Sales Ratio
1.241.151.331.411.972.73
Upgrade
EV/EBITDA Ratio
12.2910.9713.6714.1662.51-
Upgrade
EV/EBIT Ratio
20.3717.7622.6423.96--
Upgrade
EV/FCF Ratio
55.9927.57-28.56--
Upgrade
Debt / Equity Ratio
0.700.700.720.730.840.81
Upgrade
Debt / EBITDA Ratio
4.384.094.484.7319.85-
Upgrade
Debt / FCF Ratio
19.9510.27-9.55--
Upgrade
Asset Turnover
0.810.840.840.780.640.54
Upgrade
Inventory Turnover
4.034.344.604.984.603.85
Upgrade
Quick Ratio
0.580.560.590.710.760.77
Upgrade
Current Ratio
0.890.870.911.061.081.15
Upgrade
Return on Equity (ROE)
6.28%7.54%7.64%7.62%-2.61%0.36%
Upgrade
Return on Assets (ROA)
3.09%3.39%3.06%2.88%-0.72%-2.11%
Upgrade
Return on Capital (ROIC)
3.63%3.96%3.58%3.32%-0.83%-2.46%
Upgrade
Return on Capital Employed (ROCE)
9.20%9.80%8.30%6.90%--
Upgrade
Earnings Yield
4.82%5.93%4.94%5.21%-1.51%0.26%
Upgrade
FCF Yield
2.74%5.39%-1.14%5.38%-2.72%-7.29%
Upgrade
Dividend Yield
1.05%1.10%----
Upgrade
Payout Ratio
21.86%18.62%16.21%--117.13%
Upgrade
Buyback Yield / Dilution
0.29%-----
Upgrade
Total Shareholder Return
1.34%1.10%----
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.